Retrospective Data Collection and Analysis

OTHER2 trials

Sponsors

Hangzhou Institute of Medicine (HIM), Chinese Academy of Sciences, Ankara Etlik City Hospital

Conditions

Advanced CancerBreast NeoplasmsEmergency Department AdmissionMetastatic Solid TumorsMortalityOncology

Unknown Phase

Development of a Multi-omics Prediction Model for Immunotherapy Response in Triple-Negative Breast Cancer Subtypes

Active, not recruitingNCT06833723

Hangzhou Institute of Medicine (HIM), Chinese Academy of SciencesBreast Neoplasms

Start: 2025-04-17End: 2027-11-17Target: 1000Updated: 2026-01-15

90-Day Mortality After Emergency Department Discharge in Advanced Cancer

CompletedNCT07167095

Ankara Etlik City HospitalAdvanced Cancer, Emergency Department Admission, Metastatic Solid Tumors +2

Start: 2022-12-01End: 2025-03-01Updated: 2025-09-11

Related Papers

Mapping the rapid growth of multi-omics in tumor immunotherapy: Bibliometric evidence of technology convergence and paradigm shifts

Human Vaccines & Immunotherapeutics2025-04-243 citations